CSUN  Wordmark
Page Description

The following syllabus page is a three column layout with a header that contains a quicklinks jump menu and the search CSUN function. Page sections are identified with headers. The footer contains update, contact and emergency information.

BIOETHICS

Contact Information

  • Leemon McHenry
  • Philosophy
  • leemon.mchenry@csun.edu
  • Office Phone 818-677-5806
  • Fax Number
  • Office Hours--
  • ST 534

Instructional Materials

Required Text

Beauchamp et al. Contemporary Issues in Bioethics, Wadsworth/Cengage

Journal Articles

McHenry, L. and Khoshnood, M. “Blood Money: Bayer’s Inventory of HIV Contaminated Blood Products and 3rd World Hemophiliacs,” Accountability in Research,  2014. 

McHenry, L. “Of Sophists and Spin-Doctors: Industry-Sponsored Ghostwriting and the Crisis of Academic Medicine, Mens Sana Monographs, 2010.

McHenry, L. and Jureidini, J. “Privatization of Knowledge and the Creation of Biomedical Conflicts of Interest, Journal of Ethics and Mental Health, 2009.

McHenry, L. “Biomedical Research and Corporate Interests: A Question of Academic Freedom,” Mens Sana Monographs, 2008.

McHenry, L. “Ethical Issues in Psychopharmacology,” Journal of Medical Ethics, 2006.

 

 

 

 

Important Notices

Exam I --

Exam II --

Policies

Class Accommodations

 

Course Information Overview

Course Description

This course is designed for students who are considering a career in medicine. It focuses attention on complex situations in biology and medicine that require moral reflection, sound judgment and decision on the best outcomes. As such the course is divided into two parts. The first focuses on moral problems in bioethics such as abortion, euthanasia, informed consent, and just distribution of scarce medical resources. The second focuses on professional ethics of medical researchers such as conflicts of interest, interface with industry, and research and publication ethics. Particular attention will be given to departures from the ethics of responsible patient care and the corruption of evidence-based medicine by the pharmaceutical and medical device industries.